Literature DB >> 11543688

Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents.

C W Wright1, J Addae-Kyereme, A G Breen, J E Brown, M F Cox, S L Croft, Y Gökçek, H Kendrick, R M Phillips, P L Pollet.   

Abstract

The indoloquinoline alkaloid cryptolepine 1 has potent in vitro antiplasmodial activity, but it is also a DNA intercalator with cytotoxic properties. We have shown that the antiplasmodial mechanism of 1 is likely to be due, at least in part, to a chloroquine-like action that does not depend on intercalation into DNA. A number of substituted analogues of 1 have been prepared that have potent activities against both chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum and also have in common with chloroquine the inhibition of beta-hematin formation in a cell-free system. Several compounds also displayed activity against Plasmodium berghei in mice, the most potent being 2,7-dibromocryptolepine 8, which suppressed parasitemia by 89% as compared to untreated infected controls at a dose of 12.5 mg kg(-1) day(-1) ip. No correlation was observed between in vitro cytotoxicity and the effect of compounds on the melting point of DNA (DeltaT(m) value) or toxicity in the mouse-malaria model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11543688     DOI: 10.1021/jm010929+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

1.  Synthesis of 1,5-benzothiazepine derivatives bearing 2-phenoxy-quinoline moiety via 1,3-diplolar cycloaddition reaction.

Authors:  Zhi-Qiang Dong; Fang-Ming Liu; Feng Xu; Zai-Liang Yuan
Journal:  Mol Divers       Date:  2011-08-12       Impact factor: 2.943

2.  Synergistic anti-malarial action of cryptolepine and artemisinins.

Authors:  Arnold D Forkuo; Charles Ansah; Kwesi M Boadu; Johnson N Boampong; Elvis O Ameyaw; Ben A Gyan; Andrea T Arku; Michael F Ofori
Journal:  Malar J       Date:  2016-02-16       Impact factor: 2.979

3.  Design and in vitro haemolytic evaluation of cryptolepine hydrochloride-loaded gelatine nanoparticles as a novel approach for the treatment of malaria.

Authors:  Noble Kuntworbe; Raida Al-Kassas
Journal:  AAPS PharmSciTech       Date:  2012-04-05       Impact factor: 3.246

4.  Challenges and opportunities for chemistry in Africa.

Authors:  Berhanu Abegaz
Journal:  Nat Chem       Date:  2016-05-24       Impact factor: 24.427

5.  Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes.

Authors:  Sudipta Hazra; Subhalakshmi Ghosh; Sukalyani Debnath; Scott Seville; Vijay Kumar Prajapati; Colin W Wright; Shyam Sundar; Banasri Hazra
Journal:  Parasitol Res       Date:  2012-07       Impact factor: 2.289

6.  3-bromohomofascaplysin A, a fascaplysin analogue from a Fijian Didemnum sp. ascidian.

Authors:  Zhenyu Lu; Yuanqing Ding; Xing-Cong Li; Daignon R Djigbenou; Brian T Grimberg; Daneel Ferreira; Chris M Ireland; Ryan M Van Wagoner
Journal:  Bioorg Med Chem       Date:  2011-06-01       Impact factor: 3.641

7.  Recent Advances in the Chemistry and Pharmacology of Cryptolepine.

Authors:  Steven D Shnyder; Colin W Wright
Journal:  Prog Chem Org Nat Prod       Date:  2021

Review 8.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

9.  Expedient one-pot synthesis of indolo[3,2-c]isoquinolines via a base-promoted N-alkylation/tandem cyclization.

Authors:  Huy H Nguyen; James C Fettinger; Makhluf J Haddadin; Mark J Kurth
Journal:  Tetrahedron Lett       Date:  2015-09-30       Impact factor: 2.415

10.  Genomewide expression profiling of cryptolepine-induced toxicity in Saccharomyces cerevisiae.

Authors:  Marta Rojas; Colin W Wright; Benjamin Piña; José Portugal
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.